Healthcare
Edgewise Therapeutics Sees 50% Surge Following Positive Drug Update
September 19, 2024 01:25 PM PDT | By Team Kalkine MediaHeadlines,Edgewise Therapeutics' stock surged over 50%, hitting a three-year peak due to favorable updates on its cardiac drug EDG-7500.,The recent ph...
Vanda Pharmaceuticals decries FDA’s rejection of stomach paralysis d...
September 19, 2024 12:17 PM PDT | By InvezzThe company has criticized the FDA for failing to hold advisory committee meetings as well as going against the FDCA.
Impact of Major Client Loss on Progyny Shares
September 19, 2024 10:58 AM PDT | By Team Kalkine MediaHeadlines,Progyny,(NASDAQ:PGNY),shares dropped significantly following the announcement of losing a major client.,The client contributed 12-13% of Pro...
CRISPR Therapeutics Faces Decline This Year
September 19, 2024 03:34 AM PDT | By Team Kalkine MediaCRISPR Therapeutics has experienced a 21% decline in its stock value this year. Despite this drop, the biotech company continues to make progress with...
Eli Lilly Poised for Its Next Big Move Amid Stock Surge
September 19, 2024 02:47 AM PDT | By Team Kalkine MediaEli Lilly, a prominent player in the,Healthcare sector,, has experienced a significant rise in its stock price, driven by the success of its weight-lo...
Gilead Sciences stock nears its all-time high: buy or sell?
September 18, 2024 09:08 PM PDT | By InvezzGilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million settlement with American...
Stryker's Latest Acquisition and Its Impact on Stock Performance
September 18, 2024 05:19 PM PDT | By Team Kalkine MediaHeadlines,Stryker Corporation has finalized the acquisition of care.ai, a company known for its AI-driven virtual care solutions.,The acquisition aims...
Merit Medical's WRAPSODY Trial Yields Positive Results
September 18, 2024 05:16 PM PDT | By Team Kalkine MediaHeadlines,Merit Medical Systems reported positive 6-month outcomes from the WRAPSODY trial's arteriovenous (AV) fistula arm.,The trial data, presented...
Rockwell Medical Stock Soars 108.5% YTD: Is It a Top Performer?
September 18, 2024 05:13 PM PDT | By Team Kalkine MediaHeadlines,Rockwell Medical's stock has surged by over 108% year-to-date, significantly outpacing industry and benchmark growth.,The company has excell...
Teladoc Sees 12% Surge Amid Growing BetterHelp Web Traffic
September 18, 2024 04:47 PM PDT | By Team Kalkine MediaHeadlines,Teladoc Health's shares increased nearly 12%, driven by improved web traffic for its BetterHelp platform.,BetterHelp saw a 12% rise in web t...
Applied Therapeutics Soars on FDA Update
September 18, 2024 12:22 PM PDT | By Team Kalkine MediaHeadlines,Applied Therapeutics' shares surged over 70% following an FDA update on its drug approval process.,The FDA informed the company that an advi...
How Novartis plans to thrive without competing directly with Eli Lil...
September 18, 2024 06:54 AM PDT | By InvezzAs weight-loss treatments dominate the pharmaceutical market, Swiss drugmaker Novartis AG (SWX: NOVN) is choosing a different path. While competitors...
Structure Therapeutics (NASDAQ:GPCR) Announces Key Leadership Appoin...
September 17, 2024 09:47 PM PDT | By Team Kalkine MediaStructure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company specializing in novel oral small molecule therapeutics fo...
Dermata Therapeutics (NASDAQ: DRMA)(NASDAQ: DRMAW) Closes Private Pl...
September 17, 2024 09:40 PM PDT | By Team Kalkine MediaDermata Therapeutics, Inc. (NASDAQ: DRMA)(NASDAQ: DRMAW), a late-stage biotechnology company dedicated to treating medical and aesthetic skin diseases...
Healthcare Sector Eyes Trillion-Dollar Valuation with This Stock
September 17, 2024 12:13 PM PDT | By Team Kalkine MediaIn a landscape dominated by technology giants, the,healthcare sector,is witnessing the emergence of a company approaching a trillion-dollar valuation....
Novartis’ Kisqali Cuts Breast Cancer Recurrence Risk by 28%
September 17, 2024 10:54 AM PDT | By Team Kalkine MediaHeadlines,Novartis’ Kisqali (ribociclib) demonstrated a 28.5% reduction in breast cancer recurrence risk when combined with endocrine therapy, accordi...
Labcorp Expands Services with Acquisition of BioReference Health
September 17, 2024 10:52 AM PDT | By Team Kalkine MediaHeadlines,Labcorp has completed its acquisition of BioReference Health’s assets, aimed at enhancing its laboratory services and testing capabilities a...
New Covid XEC variant spreads across Europe and beyond: what you nee...
September 17, 2024 03:35 AM PDT | By InvezzAs the Covid-19 pandemic continues to evolve, a new variant known as the Covid XEC variant is starting to spread rapidly across Europe, North America,...
Why Summit Therapeutics Is Generating Buzz
September 17, 2024 02:20 AM PDT | By Team Kalkine MediaSeptember has been a noteworthy period for those closely following developments in cancer treatment. Recent advancements suggest that a significant co...
Northwest Urgent Care (NYSE:CYH) Expands with Acquisition of 10 Ariz...
September 16, 2024 10:05 PM PDT | By Team Kalkine MediaNorthwest Urgent Care, LLC, a Tucson-based subsidiary of Community Health Systems, Inc. (NYSE:CYH), has announced a significant expansion through the...